baber/WOPTO huggingface dataset:
Patent DE-326525-T1 (DE)
IPC: A23K1/00
Filed: 1989-01-20
Abstract: A process for the production of dehydrated compressed food products, said process comprising the steps, starting from base freeze-dried or dried food products, as individual products or as mixtures of products, of:   a) moistening the freeze-dried food product or the freeze-dried mixture of products up to absolute moisture amounts of about 20 % depending on the kind of food product; b) compressing the moistened product by means of power-consuming machines at pressures between 2 and 100 kg/cm<2>; c) drying the compressed product till obtaining absolute moisture amounts less than or equal to 3 %. e
Patent ES-2053426-T1 (ES)
Inventor: DAHMEN KURT
IPC: C08J7/056
Filed: 1990-11-20
Abstract: PCT No. PCT/EP90/01981 Sec. 371 Date Dec. 29, 1992 Sec. 102(e) Date Dec. 29, 1992 PCT Filed Nov. 20, 1990 PCT Pub. No. WO92/00108 PCT Pub. Date Jan. 9, 1992.The present invention relates to a powdery, water-insoluble, cross-linked resin which absorbs aqueous or serous liquids as well as blood and is composed of a) 55 to 99.9%-wt. polymerized, unsaturated, polymerizable, acid-groups-containing monomers which are neutralized to the extent of at least 25 mol-%, b) 0 to 40%-wt. polymerized, unsaturated monomers copolymerizable with a), c) 0.1 to 5.0%-wt. of a cross-linking agent, and d) 0 to 30%-wt. of a water-soluble polymer, whereby the weight amounts a) to d) relate to anhydrous polymer. The polymer is characterized by the fact that the resin powder has been coated with 0.1 to 5%-wt. of an alkylene carbonate, relative to resin powder, and heated to a temperature of 150 DEG  to 300 DEG  C. The present invention further relates to a method of producing said polymer and to the use thereof in sanitary articles, such as diapers and the like, and in absorbent constructions consisting of hydrophilic fibers and absorbing resin.
Patent ES-2046159-T1 (ES)
Title: Embalaje biodegradable con pico vertedor.
IPC: B65D5/74
Filed: 1993-01-27
Abstract: UN EMBALAJE DE MATERIAL PLEGABLE BIODEGRADABLE COMPRENDE UN PICO VERTEDOR EN LA REGION CENTRAL DE UNA PARED. EL PICO VERTEDOR CONSTITUIDO DE MATERIAL BIODEGRADABLE COMPRENDE UN CONJUNTO 37 CON DOS ALAS LATERALES 38A, 39B SOLIDARIO DE UNA PATILLAS DE AGARRE 36.
Patent ES-2100823-T1 (ES)
Title: Metodo para preparar un tejido de punto de cadeneta de ligamento de panal y el tejido obtenido con el mismo.
Inventor: CABRINI GIANNANGELO
IPC: D04B21/02
Filed: 1994-12-03
Abstract: SE PRESENTA UN METODO PARA PRODUCIR UN TEJIDO COSIDO EN CADENA QUE TIENE UN COMPONENTE FIBROSO (1), UN SEGUNDO COMPONENTE FIBROSO (2), UN TERCER COMPONENTE FIBROSO (3) Y UN CUARTO COMPONENTE FIBROSO (4), SOBRE UNA MAQUINA TEJEDORA, EN DONDE DICHO TEJIDO SE PREPARA CON UN LIGAMENTO DEL HILO CELULAR O EN FORMA DE PANAL.
Patent CY-1106875-T1 (CY)
Inventor: MASIGNANI VEGA
IPC: A61P31/04
Filed: 2007-09-17
Abstract: W099/24578 discloses a large number of proteins from Neisseria meningitidis and Neisseria gonhorroeae The present invention relates to fragments of the protein having the amino acid sequence set forth in SEQ ID NO:650 of W099/24578, which fragments comprise at least one antigenic determinant of said protein.
Patent CY-1110062-T1 (CY)
Inventor: CALAIS Béatrice
IPC: C07D307/60
Filed: 2009-08-24
Abstract: This invention is related to a polymorphic B Form of 3-(cyclopropylmethoxy)-4-Ä4-(methylsulfonyl)phenylÜ-5,5-dimethyl-5H-fu ran-2-one characterized by the powder x-ray diffraction pattern represented in figure 2.
Patent CY-1115620-T1 (CY)
Title: Νεα μεθοδος συνθεσης ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
Inventor: RENAUD JEAN-LUC
IPC: C07D223/16
Filed: 2014-10-14
Abstract: Μέθοδος σύνθεσης της ιβαμπραδίνης του τύπου (Ι): των αλάτων προσθήκης αυτής με ένα φαρμακευτικώς αποδεκτό οξύ και των υδριτών αυτής. Φάρμακα.
Patent CY-1120739-T1 (CY)
Title: Αντισωματα αντι-il-6, συνθεσεις, μεθοδοι και χρησεις
Inventor: CHEN YAN
IPC: C07K16/24
Filed: 2018-08-21
Abstract: Ένα αντίσωμα αντι-ILo, που περιλαμβάνει απομονωμένα νουκλεϊκά οξέα τα οποία κωδικεύουν τουλάχιστον ένα αντίσωμα αντι-ILo, φορείς, κύτταρα ξενιστές, διαγονιδιακά ζώα ή φυτά και μέθοδοι για να γίνουν και να χρησιμοποιηθούν όλα αυτά, έχουν εφαρμογές σε διαγνωστικές ή/και θεραπευτικές συνθέσεις, μεθόδους και συσκευές.
Patent CY-1122592-T1 (CY)
Title: Μη-στεροειδικοι διαμορφωτες υποδοχεα γλυκοκορτικοειδους για τοπικη χορηγηση φαρμακευτικων ουσιων
Inventor: JOHNSON PATRICK STEPHEN
IPC: C07D417/14
Filed: 2020-02-06
Abstract: Η παρούσα εφεύρεση σχετίζεται με ένωση σύμφωνα με τον τύπο (Ι) όπου η R1 επιλέγεται από την ομάδα που αποτελείται από 5- και 6-μελές ετεροαρύλιο, (C1-C6)αλκύλιο, (C3-C6)κυκλοαλκύλιο, (4-6)μελές ετεροκυκλοαλκύλιο και φαινύλιο· η R2 επιλέγεται από (C1-C3)αλκύλιο και αλογονο(C1-C3)αλκύλιο· η R3 επιλέγεται από φαινύλιο, 5-μελές ετεροαρύλιο και 6-μελές ετεροαρύλιο· η R4 επιλέγεται από υδρογόνο, αλογόνο, (C1-C4)αλκύλιο και αλογονο(C1-C4)αλκύλιo· η Χ1 επιλέγεται από CΗ, C(Rb) και Ν, η Χ2 επιλέγεται από CΗ και Ν· η Υ επιλέγεται από -ΝΗ- και -Ο-· m είναι 0 ή 1· n είναι 0 ή 1· L αντιπροσωπεύει δεσμό, -Ο-, -ΝΗ- ή -Ν(Rc)-· ή αποδεκτά από φαρμακευτική άποψη άλατα, συμπλέγματα ενυδάτωσης ή συμπλέγματα επιδιαλύτωσης αυτής. Η εφεύρεση σχετίζεται περαιτέρω με ενδιάμεσα για την παρασκευή των εν λόγω ενώσεων, με τις εν λόγω ενώσεις για χρήση στη θεραπεία, με φαρμακευτικές συνθέσεις που περιλαμβάνουν τις εν λόγω ενώσεις, με μεθόδους αγωγής παθήσεων με τις εν λόγω ενώσεις, και με τη χρήση των εν λόγω ενώσεων στην παραγωγή φαρμάκων.
Patent CY-1123126-T1 (CY)
Title: Συνθεσεις για την αγωγη γαστρεντερικης φλεγμονης
Inventor: PHILLIPS ELAINE
IPC: A61K38/35
Filed: 2020-03-26
Abstract: Στο παρόν παρέχονται μέθοδοι για αγωγή, πρόληψη ή ανακούφιση των συμπτωμάτων και της φλεγμονής που σχετίζονται με φλεγμονώδεις νόσους και παθήσεις της γαστρεντερικής οδού, για παράδειγμα, εκείνων που εμπλέκουν τον οισοφάγο. Επίσης στο παρόν παρέχονται φαρμακευτικές συνθέσεις χρήσιμες για τις μεθόδους της παρούσας εφεύρεσης.
Patent CY-1124080-T1 (CY)
Title: Μεθοδος υγροποιησης φυσικου αεριου με κλειστο τριπλο κυκλωμα ψυκτικου αεριου
Inventor: BONNISSEL MARC
IPC: F25J1/02
Filed: 2021-02-22
Abstract: Η παρούσα εφεύρεση έχει ως αντικείμενο μία μέθοδο υγροποίησης ενός φυσικού αερίου που περιλαμβάνει κυρίως μεθάνιο, κατά την οποία υγροποιείται το εν λόγω φυσικό αέριο προς υγροποίηση με την εκτέλεση των επόμενων συνακόλουθων βημάτων: (a) κυκλοφορία του εν λόγω φυσικού αερίου προς υγροποίηση το οποίο κυκλοφορεί μέσα σε 3 εναλλάκτες θερμότητας συναρμολογημένους σε σειρά εντός των οποίων αυτό ψύχεται σε (θερμοκρασία) Τ3, όπου η Τ3 είναι μικρότερη ή ίση της θερμοκρασίας υγροποίησης του εν λόγω φυσικού αερίου σε ατμοσφαιρική πίεση, και (b) κυκλοφορία σε κλειστό κύκλωμα τουλάχιστον: - μίας πρώτης ροής ψυκτικού αερίου σε πίεση Ρ1 μικρότερη της Ρ3 που εισέρχεται εντός του τρίτου εναλλάκτη και εξέρχεται από τον εν λόγω πρώτο εναλλάκτη, όπου η εν λόγω πρώτη ροή λαμβάνεται με εκτόνωση εντός ενός πρώτου εκτονωτήρα ενός πρώτου τμήματος μίας εν λόγω δεύτερης ροής υπό (πίεση) Ρ3 μεγαλύτερη της Ρ2, όπου η εν λόγω δεύτερη ροή κυκλοφορεί σε ομορροή με την εν λόγω ροή φυσικού αερίου εισερχόμενη εντός του εν λόγω πρώτου εναλλάκτη και εξερχόμενη από τον εν λόγω δεύτερο εναλλάκτη, και - μίας τρίτης ροής υπό πίεση Ρ2 μεγαλύτερη της Ρ1 και μικρότερη της Ρ3 που κυκλοφορεί σε ομορροή με την εν λόγω πρώτη ροή, εισερχόμενη εντός του εν λόγω δεύτερου εναλλάκτη και εξερχόμενη από τον εν λόγω πρώτο εναλλάκτη, που λαμβάνεται με εκτόνωση εντός ενός δεύτερου εκτονωτήρα ενός δεύτερου τμήματος της εν λόγω δεύτερης ροής η οποία εξέρχεται από τον εν λόγω πρώτο εναλλάκτη, (c) όπου η εν λόγω δεύτερη ροή ψυκτικού αερίου υπό πίεση Ρ3 λαμβάνεται με συμπίεση δια μέσου τουλάχιστον δύο συμπιεστών πρώτου και δεύτερου τοποθετημένων σε σειρά και συζευγμένων με τους εν λόγω εκτονωτήρες πρώτο και δεύτερο.
Patent HR-P20110643-T1 (HR)
Title: High affinity binding site of hgfr and methods for identification of antagonists thereof
Inventor: COMOGLIO PAOLO MARIA
IPC: A61K38/18
Filed: 2011-09-07
Abstract: Use of a polynucleotide encoding or a polypeptide comprising at least the extra-cellular IPT-3 and IPT-4 domains of hepatocyte growth factor receptor for the screening and/or development of pharmacologically active agents useful in the treatment of cancer, preferably a cancer with dysregulation of hepatocyte growth factor receptor.
Patent SI-1518361-T1 (SI)
Title: Method for determining an optimal transmission path in a data network
Inventor: SCHOENLEITNER ARNOLD
IPC: H04L12/56
Filed: 2003-06-02
Abstract: The invention relates to a method for determining an optimal transmission path in a data network, wherein the network subscribers (1-14) exchange data in a wireless manner, preferably by radio communication, along a plurality of transmission routes. A first subscriber of the transmission route transmits a search request which can be used as stations of transmission paths by subscribers (1-14) who receive said search request, measure the receiving field intensity, add an identifier to the search request and the measured receiving field intensity, whereupon the search request is subsequently transmitted. The network subscriber (1-14) who is the second subscriber of the transmission route measures the receiving field intensity of the search request and adds to the search request, that which out of all the received search requests contains the optimum transmission route in terms of number of stations and quality of the links between said stations. Said second subscriber of the transmission route transmits said search request thus determined. Each network subscriber (1-14), who receives said search request and whose identifier is contained in said search request stores the identifier registered in the search request prior to his or her identifier as an identifier of a subscriber whose signals are to be retransmitted and retransmits said search request.
Patent SI-2266188-T1 (SI)
Title: Permanent magnet rotor with flux concentrating pole pieces
Inventor: PENNANDER LARS-OLOV
IPC: H02K1/00
Filed: 2009-03-18
Abstract: A permanent magnet machine is provided including a stator and a rotor, the rotor being adapted to rotate relative to the stator, the rotor including a plurality of permanent magnets separated in the circumferential direction from each other by radially extending rotor pole pieces for concentrating the magnetic flux from the permanent magnets, the stator having a structure that defines radial limits of an air gap between the stator and the rotor for communicating magnetic flux between the stator and the rotor, wherein at least some of the permanent magnets extend radially outside the radial limits of the air gap as defined by the stator structure.
Patent SI-3075862-T1 (SI)
Title: Devices and assays for diagnosis of sinusitis
Inventor: SKRABA JOSEPH
IPC: G01N33/00
Filed: 2016-03-30
Abstract: Methods and kits for sampling mucous from within a sinus to determine if a single sample includes one or more bacterial types indicating bacterial sinusitis.
Patent TR-200606871-T1 (TR)
Title: Karboksilik asitlerin seçici çözücülerle kompleks oluşturarak saflaştırılması.
Inventor: CHOU TAI-LI
IPC: C07C51/42
Filed: 2005-04-08
Abstract: Karboksilik asitlerin saflaştırılmasına dair bir usul ve cihaz açıklanmaktadır. İşlenmemiş karboksilik asit içeren bir karışım seçici bir kristalizasyon çözücüsü ile temas ettirilerek karboksilik asitten ve seçici kristalizasyon çözücüsünden oluşan bir tuz kompleksi bulamacı oluşturulur. Tuz kompleksi geri kazanılır ve isteğe bağlı olarak serbest karboksilik asitin geri kazanılması için ayrıca işleme tabi tutulur. Buluşa ait usul ve cihaz özellikle tereftalik asit gibi aromatik dikarboksilik asitlerin saflaştırılması için uygundur. Mevcut buluş, karboksibenzaldehitin karşılık gelen ftalik asite oksidasyonuyla işlenmemiş ftalik asitlerde karboksibenaldehit izomerlerinin yol açtığı kirlenmeyi de önler.
Patent DE-3750836-T2 (DE)
Inventor: CLARK MARY
IPC: A61K33/30
Filed: 1987-03-20
Granted: 1995-05-04
Abstract: Treatment of open wounds in human tissue (esp. skin) is effected by (a) treating the wound area with an aq. medium having a pH low enough to cause at least partial ionisation of basic amino acids naturally present in adjacent tissues and to bring them into soln. at the surface of the wound area, and (b) treating the wound area with a basic ointment having a pH high enough to activate amino acids at the surface of the wound. The aq. medium has a pH of 4.3-6.8 and contains a chelating agent for basic amino acids, esp. ZnCl2. It may also contain a vitamin B cpd. (esp. pyridoxine,HCl) and dexgtrose. The ointment has a pH of 6.5-9 and comprises a basic material (I), anhydrous lanolin, a hydrophilic ointment base and a water-soluble Zn salt, opt. together with vitamin A as antioxidant. (I) is pref. CaCO3, Mg(OH)2 or Al(OH)3. The concn. of the Zn salt is 0.15-15 wt.% based on (I). -
Patent DE-3782894-T2 (DE)
Inventor: PEDERSEN HELSTED
IPC: H03M9/00
Filed: 1987-03-03
Granted: 1993-04-08
Abstract: A method and apparatus for conversion of a plurality of information signals from parallel to serial representation and vice versa. According to the invention the time delay introduced by the use of ordinary shift registers is obviated by shortly transferring of energy to or from specified locations of an energy propagation path. When using e.g. microwave energy, serial information signals may be transmitted by transferring electrical charges to specified locations of a microstrip path at predetermined points of time and the parallel information may be retrieved from said serial information signals by sensing specified locations of the microstrip path at corresponding points of time.
Patent DE-3783348-T2 (DE)
Inventor: ROSCH REINHARD
IPC: H04M19/00
Filed: 1987-11-20
Granted: 1993-04-22
Abstract: A typical active impedance line feed circuit includes tip and ring amplifiers (20, 40) being controlled in response to signals at tip and ring voltage taps (6, 7) by a control circuit (60) to exhibit a.c. impedance and d.c. resistance characteristics for the purpose of supplying energizing current via tip and ring terminals (2, 3) for tip and ring leads of two wire communication line. In one example of the active impedance line feed circuit, improved operational tolerance of longitudinal interference and of a ground fault condition is provided by a d.c. amplifier (210a) being responsive to voltages at the tip and ring terminals. The circuit is characterized in that an inverting input of the d.c. amplifier is connected via resistors (212a, 313a) to the tip and ring voltage taps. In operation, the d.c. amplifier provides complete cancellation of all common mode signals at the tip and ring voltage taps. A compensation amplifier (235) is also connected between the tip and ring voltage taps and is responsive to the output of a control amplifier (231) for compensating for non-symmetrical current, the non-symmetrical current being introduced between the tip and the ring voltage taps by normal operation of the control circuit. Thereby, a threshold of ground fault current limiting action is substantially constant under all operating conditions. The d.c. amplifier is conveniently manufacturable in integrated circuit technology along with the remaining amplifiers in the active impedance line feed circuit.
Patent DE-3850993-T2 (DE)
Inventor: MISAKI ATSUSHI
IPC: C07K16/00
Filed: 1988-04-15
Granted: 1994-12-01
Abstract: Monoclonal antibodies with high affinity to human pancreatic PLA2, the production thereof, hybridomas producing them and the immunoassay for human pancreatic PLA2 using them.
Patent DE-3852812-T2 (DE)
Inventor: SUPPIAH SELLATHURAI
IPC: B01J37/02
Filed: 1988-11-09
Granted: 1995-05-18
Abstract: Sprayable dispersions or shaped articles are made from a material of high surface area by blending the material with polytetrafluoroethylene in the presence of a liquid. The blended material may be shaped into an article or coated onto the surface of an article. The article is then heated above 327 DEG C. The resulting product retains high surface area, and can be used as a catalyst or catalyst support, a biological support, or an adsorbent.
Patent DE-3873891-T2 (DE)
Inventor: CAILLIOT SERGE
IPC: A47J17/18
Filed: 1988-05-25
Granted: 1993-03-25
Abstract: PCT No. PCT/FR88/00260 Sec. 371 Date Jan. 27, 1989 Sec. 102(e) Date Jan. 27, 1989 PCT Filed May 25, 1988 PCT Pub. No. WO88/09639 PCT Pub. Date Dec. 15, 1988.In an appliance for peeling fruit and vegetables, the appliance comprising an electric motor (1) driving a rotor (2) inside a cover (6), the axis of rotation (21) of the rotor being perpendicular to the surface to be peeled, and the rotor being loosely or pivotally mounted on the axis of rotation and being driven at a speed such that the tangential speed of the blades (16) carried by the rotor is at least equal to 7 meters per second.
Patent DE-3881936-T2 (DE)
Inventor: HAMADA SHUNICHI
IPC: D06N3/18
Filed: 1988-04-07
Granted: 1993-09-30
Abstract: A laminate comprising a base fabric, an intermediate layer formed on said fabric comprising a polyolefin, at least a part of which is modified by grafting with at least one monomer selected from unsaturated carboxylic acids and derivatives thereof, and a surface layer formed on said intermediate layer comprising a thermoplastic elastomer, is suitable for use as an artificial leather.
Patent DE-3882704-T2 (DE)
Inventor: WEHNER GOTTFRIED K
IPC: C23C14/34
Filed: 1988-03-24
Granted: 1994-01-13
Abstract: A method for sputter deposition of films or coatings over large areas or at widely different substrate locations relative to the target where the coating is of exactly the same component composition as the target from where the material is being sputtered. This is accomplished by sputtering in a noble gas or other vapor plasma through ion bombarding of at least one spherical or partially spherical target. Superconductors, as well as many other multicomponent materials, can be sputter deposited on a substrate with unchanged composition by utilizing a spherical target in a low gas or vapor pressure plasma.
Patent TR-199801942-T2 (TR)
Inventor: FEENSTRA ROELOF WILLEM
IPC: A61K31/357
Filed: 1997-03-20
Abstract: The invention relates to a group of new piperazine and piperidine compounds having interesting pharmacological properties. It has been found that compounds of formula (a) wherein A represents a heterocyclic group of 5-7 ring atoms wherein 1-3 heteroatoms from the group O, N and S are present; R1 is hydrogen or fluoro; R2 is C1-4-alkyl, C1-4-alkoxy or an oxo group, and p is 0, 1 or 2; Z represents carbon or nitrogen, and the dotted line is a single bond when Z is nitrogen, and a single or double bond when Z is carbon; R3 and R4 independently are hydrogen or C1-4-alkyl; n has the value 1 or 2; R5 is halogen, hydroxy, C1-4-alkoxy or C1-4-alkyl, and q is 0, 1, 2 or 3; Y is phenyl, furanyl or thienyl, which groups may be substituted with 1-3 substituents of the group hydroxy, halogen, C1-4-alkoxy, C1-4-alkyl, cyano, aminocarbonyl, mono- or di-C1-4-alkylaminocarbonyl; and salts thereof show high affinity for both the dopamine D2 and serotonin 5-HT1A receptors.
Patent TR-199902044-T2 (TR)
Title: Gaz-sivi tepkimelerini etkinlestirmek için bir sürekli yöntem.
Inventor: FANELL PASQUALE
IPC: B01J19/00
Filed: 1998-02-04
Abstract: Mevcut bulus, gaz-içinde-sivi dagilim mekanizmasi ile olusan gaz-sivi tepkimelerini etkinlestirmek için bir islem ile ilgilidir.        Özellikle, mevcut bulus, en az bir aktif hidrojeni olan bir zincir baslatici üzerinde bir poli-ekleme tepkimesi araciligi ile, alkilen oksitlerin poli- eklemelerinin üretimi için bir sürekli islem ile ilgilidir.
Patent TR-199902873-T2 (TR)
Inventor: LEEMHUIS JOHANNES ANTONIUS JOS
IPC: A61K31/56
Filed: 1998-05-28
Abstract: The invention relates to 17beta-allyloxy(thio)alkyl-androstane derivatives having general formula (I) wherein R1 is (H, OR), (H, OSO3H) or NOR; with R being H, (C1-6)alkyl or (C1-6)acyl; each of R2 and R3 is independently hydrogen or (C1-6)alkyl; n is 0, 1 or 2; X is O, S, S(O) or S(O)2; each of R4 and R5 is independently hydrogen or (C1-4)alkyl; each of R6, R7 and R8 is independently hydrogen, phenyl, halogen or (C1-4)alkyl, optionally substituted by hydroxy, (C1-4) alkoxy or halogen; or R7 and R8 together with the carbon atom to which they are bound form a (C3-6)cycloalkane ring; or R6 and R7 together with the carbon atoms to which they are bound form a (C5-6) cycloalkene ring; and wherein the dotted lines indicate a DELTA7 or a DELTA8 double bond, or a pair of conjugated double bonds selected from DELTA7,14, DELTA8,14 and DELTA6,8(14); or a pharmaceutically acceptable salt thereof. The compounds of the invention have meiosis activating activity and can be used for the control of fertility.
Patent DE-60008418-T2 (DE)
Inventor: PHELPS DAVID
IPC: C07C63/72
Filed: 2000-11-21
Granted: 2005-03-03
Abstract: Xylene derivatives, such as chloro-ortho-xylene, are oxidized in a solvent in the presence of at least one metal catalyst with addition of promoter after the reaction has proceeded to an intermediate stage of conversion to product mixture. The product comprises chlorophthalic acid or chlorophthalic anhydride.
Patent DE-60009093-T2 (DE)
Inventor: AMOS RICHARD MICHAEL
IPC: G02B6/12
Filed: 2000-09-05
Granted: 2005-02-17
Abstract: A method of growing robust large area colloidal photonic crystals and devices produced thereby. A suspension of monosized colloidal spheres (1) is subjected to a composite shear (6) by applying a sequential set of shearing forces. The crystalline layers within the colloid experience shearing forces with components in both x and y directions, forcing the colloid into a singe face-centered-cubic structure in preference to a twinned face-centered-cubic structure. The method may also comprise the use of a dispersion medium which is capable of undergoing a controllable phase change from a liquid phase to a solid phase. The crystal may be fixed into a single face-centered cubic structure.
Patent DE-60018965-T2 (DE)
Inventor: MAINO GIULIANO
IPC: A61C7/28
Filed: 2000-11-24
Granted: 2006-03-23
Abstract: The invention discloses an anchor screw (10) to the palatal vault for orthodontic correction treatments comprising: a lower threaded portion (1) adapted to be screwed to the bone; a substantially cylindrical central portion (2) protruding from the bone and the gum adapted to allow anchorage of traction and/or thrust orthodontic devices; an upper portion (3) provided with movement means (4) to screw and unscrew the screw. The central portion (2) has a reduced diameter zone (6) in comparison with the diameter of the cylindrical portion and at least a hole (5) for the passage of orthodontic devices such as round and/or rectangular/square wires.
Patent DE-60019981-T2 (DE)
Inventor: HOLMA MAUNU
IPC: H04W92/12
Filed: 2000-12-11
Granted: 2006-02-23
Abstract: The present invention proposes a method for configuring a data transmission interface in a communication network adopting a transmission protocol for transmission of data in units of grouped data, wherein said transmission interface is the interface (Iub) between an access network control node (RNC 1 ) and an access node (BS 1 -BS 6 ) adapted to establish a communication to a terminal, and wherein said communication network has a topology such that an access node (BS 2 , BS 3 , BS 5 , BS 6 ) is connected to said access network control node (RNC 1 ) by an intermediate of at least one further access node (BS 1 ,BS 1 -BS 2 , BS 4 , BS 4 ), said method comprising the steps of: deriving a delay information of the delay experienced by data transmission between a respective network access node (BS 1 -BS 6 ) and said access network control node (RNC), calculating a delay difference between two consecutive access nodes (BS 1 -BS 2 , BS 2 -BS 3 , BS 4 -BS 5 , BS 4 -BS 6 ) based on said delay information, and modifying the delay experienced by data transmission for the respective access node which is identified by the respective smaller delay. Also, the present invention proposes an accordingly adapted access network control node as well as accordingly adapted access nodes.